Search details
1.
A prospective, multicenter pilot study to investigate the feasibility and safety of a 1-year controlled exercise training after adjuvant chemotherapy in colorectal cancer patients.
Support Care Cancer
; 26(4): 1345-1352, 2018 Apr.
Article
in English
| MEDLINE | ID: mdl-29168033
2.
A phase 1 dose escalation study of BI 831266, an inhibitor of Aurora kinase B, in patients with advanced solid tumors.
Invest New Drugs
; 33(2): 409-22, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25529193
3.
Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial.
Haematologica
; 100(7): 955-63, 2015 Jul.
Article
in English
| MEDLINE | ID: mdl-25911553
4.
Rituximab plus subcutaneous cladribine in patients with extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue: a phase II study by the Arbeitsgemeinschaft Medikamentose Tumortherapie.
Haematologica
; 98(2): 264-8, 2013 Feb.
Article
in English
| MEDLINE | ID: mdl-22983582
5.
Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
N Engl J Med
; 360(7): 679-91, 2009 Feb 12.
Article
in English
| MEDLINE | ID: mdl-19213681
6.
Prognostic value of number of removed lymph nodes, number of involved lymph nodes, and lymph node ratio in 7502 breast cancer patients enrolled onto trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG).
Ann Surg Oncol
; 19(6): 1808-17, 2012 Jun.
Article
in English
| MEDLINE | ID: mdl-22207051
7.
Rituximab serum concentrations during immuno-chemotherapy of follicular lymphoma correlate with patient gender, bone marrow infiltration and clinical response.
Haematologica
; 97(9): 1431-8, 2012 Sep.
Article
in English
| MEDLINE | ID: mdl-22511498
8.
Sentinel node biopsy after primary chemotherapy in breast cancer: a note of caution from results of ABCSG-14.
Breast J
; 17(3): 230-8, 2011.
Article
in English
| MEDLINE | ID: mdl-21450019
9.
Dose-dense therapy improves survival in aggressive non-Hodgkin's lymphoma.
Ann Hematol
; 89(3): 273-82, 2010 Mar.
Article
in English
| MEDLINE | ID: mdl-19693500
10.
Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.
Clin Cancer Res
; 14(7): 2082-7, 2008 Apr 01.
Article
in English
| MEDLINE | ID: mdl-18381948
11.
Multicenter phase II study of pegylated liposomal doxorubicin in combination with vinorelbine as first-line treatment in elderly patients with metastatic breast cancer.
Onkologie
; 32(1-2): 18-24, 2009 Feb.
Article
in English
| MEDLINE | ID: mdl-19209014
12.
Intensive treatment strategies in advanced-stage Hodgkin's lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trials.
Lancet Haematol
; 5(10): e462-e473, 2018 Oct.
Article
in English
| MEDLINE | ID: mdl-30290903
13.
ASCO update on lymphoma.
Memo
; 10(4): 218-219, 2017.
Article
in English
| MEDLINE | ID: mdl-29250199
14.
Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients - AGMT_GASTRIC-3.
Anticancer Res
; 37(10): 5553-5558, 2017 10.
Article
in English
| MEDLINE | ID: mdl-28982869
15.
Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).
Eur J Cancer
; 58: 112-21, 2016 May.
Article
in English
| MEDLINE | ID: mdl-26990931
16.
Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial.
Lancet Haematol
; 3(7): e317-29, 2016 Jul.
Article
in English
| MEDLINE | ID: mdl-27374465
17.
Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer--Austrian Breast and Colorectal Cancer Study Group Trial 5.
J Clin Oncol
; 20(24): 4621-7, 2002 Dec 15.
Article
in English
| MEDLINE | ID: mdl-12488405
18.
Randomized trial of tamoxifen versus tamoxifen plus aminoglutethimide as adjuvant treatment in postmenopausal breast cancer patients with hormone receptor-positive disease: Austrian breast and colorectal cancer study group trial 6.
J Clin Oncol
; 21(6): 984-90, 2003 Mar 15.
Article
in English
| MEDLINE | ID: mdl-12637461
19.
Treatment of Patients With Myelodysplastic Syndrome With Lenalidomide in Clinical Routine in Austria.
Clin Lymphoma Myeloma Leuk
; 15(11): e143-9, 2015 Nov.
Article
in English
| MEDLINE | ID: mdl-26422252
20.
Lapatinib-plus-pegylated liposomal doxorubicin in advanced HER2-positive breast cancer following trastuzumab: a phase II trial.
Anticancer Res
; 35(1): 517-21, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-25550597